Portland, Oregon, September 14, 2000- Agritope, Inc. (Nasdaq: AGTO) and
Rohm and Haas Company (NYSE: ROH)
today announced that they have entered into a technology development and
marketing agreement to create a new plant
transformation marker selection system for use in agricultural
biotechnology. When fully developed, the
Agritope-Rohm and Haas transformation system will permit the rapid creation of improved plant varieties with traits
valuable to both growers and consumers.
With this new transformation marker system, only transformed
plants will produce an easily detected,
naturally-occurring plant compound that will enable the extremely efficient identification of transformed plants in the
laboratory. This improved method will not use antibiotic or herbicide
resistance in the selection process. An added
benefit of this system is that the marker components will be rapidly eliminated from the plant via conventional plant
breeding, facilitating the
production of transgenic plants that contain only
DNA of plant or synthetic origin.
This agreement brings together Rohm and Haas’ ligand-inducible
gene expression technology and Agritope’s
proprietary visual marker gene. Rohm and Haas is contributing synthetic ecdysone
receptors and proprietary ligand
inducer
chemistry that precisely regulates
gene expression. Combining this technology with Agritope’s visual marker
gene of plant origin and expertise in plant transformation and
regeneration is expected to result in a new transformation
marker system that can be used in a wide variety of
crops.
"Agritope evaluated a variety of potential inducible gene
Expression technologies and concluded that the Rohm and
Haas system is superior," said Adolph J.
Ferro, president and chief executive officer of Agritope. "We are enthusiastic
about having an opportunity to work with a well-respected corporation of the caliber of Rohm and Haas."
"Rohm and Haas has conducted pioneering research on ligand
chemistry and receptor
biology for over fifteen years,"
noted Thomas Tillett, Rohm and Haas
biotechnology Business Manager. "Our ligand-inducible gene expression
system provides tightly regulated, highly inducible gene expression under the control of safe and effective ligand
inducers. We are looking forward to
partnering with Agritope to develop this important enabling technology for the
agricultural biotechnology industry."
The agreement provides that the research program will be conducted at both Agritope and Rohm and Haas facilities.
Rohm and Haas will manufacture the ligand and market the transformation marker system. Royalties will be shared
equally by both parties.
In July 1999, Rohm and Haas announced its first partnership in
gene regulation with the
Formation of RHeoGene LLC, a
joint venture with Argonex, Inc (Charlottesville VA). RHeoGene is developing technology for the controlled expression
of
genes for use in cell-based assays for
drug discovery and in human
gene therapy.
Rohm and Haas is a specialty chemical company whose products consistently improve the quality of life for people
around the world. Rohm and Haas technology is found in paintings and
coatings,
adhesives and
sealants, household
products, personal computers and electronic components, and
construction materials. It also brings
food to the
table-
fruits and
vegetables-and salt, an essential ingredient for life. Rohm and Haas has annual
sales of approximately
$7 billion and employs more than 21,000 people. The company operates approximately 150 manufacturing and research
sites in 25 countries around the world.
Agritope is an Oregon-based agricultural
functional genomics and biotechnology company that develops improved
plant products and provides technology to the agricultural industry. Its fruit and vegetable division specializes in the
development of improved fruit, vegetable and flower varieties. Agrinomics LLC, its 50% owned joint venture with
Aventis CropScience (NYSE: AVE), conduc